Preet Bharara, the United States Attorney for the Southern District of New York, announced that JOSEPH F. SKOWRON III, a/k/a “Chip Skowron,” a former portfolio manager of the health care unit of a hedge fund group (the “Hedge Fund”), was sentenced today to five years in prison for his participation in a conspiracy to engage in insider trading and obstruction of justice. SKOWRON used material, non-public information (“Inside Information”) that he received from Yves Benhamou, a doctor who served as an advisor on a clinical drug trial, to avoid approximately $30 million in trading losses. In addition, SKOWRON lied and urged Benhamou to lie to the U.S. Securities and Exchange Commission (“SEC”) during an investigation into SKOWRON’s trading. SKOWRON pled guilty on August 15, 2011, to one count of conspiracy to commit securities fraud and obstruct justice. He was sentenced today by U.S. District Judge Denise L. Cote.
Manhattan U.S. Attorney Preet Bharara said: “Chip Skowron’s medical training and expertise, along with his knowledge of the health care industry, undoubtedly gave him a legitimate trading edge. But that wasn’t enough—he still took a corrupt path to protect his hedge fund and himself from sustaining a multi-million-dollar loss, and then corruptly tried to obstruct the government’s investigation. As we’ve witnessed in case after case, the desire to win at any cost, including breaking the law, has a steep price that Chip Skowron will now pay.”
According to the Information, other court documents filed in the case, and statements made during the guilty plea and sentencing proceedings:
During the period of the insider trading scheme, SKOWRON was responsible for the Hedge Fund’s investment decisions in public companies, including the biopharmaceutical company Human Genome Sciences, Inc. (“HGSI”), that were involved in the development of drugs to treat hepatitis C. Benhamou was a medical doctor with an expertise in hepatitis treatment who served on an HGSI steering committee that oversaw a clinical trial of a drug called Albuferon. At the same time, Benhamou also worked as a consultant for an expert networking firm that, for a fee, put him in contact with portfolio managers and other investors at hedge funds, including SKOWRON, who purchased and sold securities in the healthcare sector.
Beginning in April 2007, SKOWRON developed a personal and financial relationship with Benhamou independent of the expert networking firm. For example, SKOWRON gave Benhamou 5,000 euros in cash during a meeting in Barcelona, Spain. He also paid some of Benhamou’s expenses, including $4,624.83 in September 2007 for a New York City hotel room for him and his wife. SKOWRON also offered to hire Benhamou as a consultant or permanent advisor to a new hedge fund. SKOWRON gave these benefits to Benhamou to encourage him to provide Inside Information about the Albuferon clinical drug trial. Benhamou understood that SKOWRON would buy or sell HGSI stock on the basis of the Inside Information.
For example, on January 18, 2008, after learning from Benhamou that HGSI’s independent safety committee had recommended to discontinue a portion of the clinical trial following serious adverse side effects suffered by two patients, SKOWRON directed a trader at the Hedge Fund to “sell the hgsi,” “all of it.” On January 22, 2008, the day before HGSI announced it would discontinue a portion of the trial, Benhamou disclosed this information, as well as the potential of a press release from HGSI, to SKOWRON. While on the phone with Benhamou, SKOWRON sent an instant message to a trader at the Hedge Fund, urging him to sell the remaining HGSI shares more quickly. As a result of those communications, SKOWRON caused the Hedge Fund to sell more than six million shares of HGSI, thereby avoiding approximately $30 million in losses.
In addition, SKOWRON and Benhamou undertook efforts to conceal the insider trading scheme from regulatory authorities. Specifically, beginning in February 2008 after the SEC began investigating the Hedge Fund’s trading in HGSI stock, SKOWRON lied to the SEC and induced Benhamou to lie to the SEC by falsely denying that they had discussed the serious adverse events before they were made public.
************************************************************************
Report Securities Fraud by Calling 1-888-482-6825 or by visiting
www.reportsecuritiesfraud.net
1 comment:
I am so happy today because God has done it for me after going through hard times with other loan lenders and nothing works out, I was about to lose my faith and hope but I still have to stand strong and pursue what I am looking for. I am happy today because God has directed me to the best Loan Company and I didn't regret anything after contacting them and my heart desire was granted and I was given the said amount I requested for (300,000.00 USD), the money was paid into my account after two weeks of talking with the company and they didn't stress me or give me any headache in getting this loan from them, others of my family members and friends I directed to them all got their loan too, I would love you to contact pedroloanss@gmail.com / whatsapp +1-8632310632 . and get your loan quickly and this is safe and fast, you that have loose hope, faith and everything you have all just in the name of getting a loan and nothing work out, bet me if you try this man called Pedro Jerome , you will never regret anything and your loan request will be approve and it will be paid directly into your bank account, so hurry now and contact quick response on WhatsApp +1-8632310632. ask for any type of Loan, and it will be granted to you. I wish you the best
Post a Comment